Previous Close | 16.31 |
1-Year Change | -23.43% |
6-Months Change | 0.49% |
3-Months Change | -29.67% |
Moving Avg (50d) | 21.534 |
Moving Avg (200d) | 20.922 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 0.989B |
Beta (3-Years) | 1.07 |
Revenue Growth (ttm) | -51.09% |
Net Profit Margin (ttm) | -81.94% |
Return On Assets (ttm) | -15.29% |
EPS (ttm) | -2 |
PE Ratio (ttm) | -8.15 |
Dividend Yield | % |
Asset Description: | Xencor, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2025-01-27 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
16.636 | 17.125 | 17.452 | 17.941 | 18.756 | 19.572 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Biotechnology |
Country: | United States |